Cargando…
Understanding competing risks: a simulation point of view
BACKGROUND: Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks. This is not always well accounted for in the applied literatur...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135581/ https://www.ncbi.nlm.nih.gov/pubmed/21639902 http://dx.doi.org/10.1186/1471-2288-11-86 |
_version_ | 1782208127583649792 |
---|---|
author | Allignol, Arthur Schumacher, Martin Wanner, Christoph Drechsler, Christiane Beyersmann, Jan |
author_facet | Allignol, Arthur Schumacher, Martin Wanner, Christoph Drechsler, Christiane Beyersmann, Jan |
author_sort | Allignol, Arthur |
collection | PubMed |
description | BACKGROUND: Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks. This is not always well accounted for in the applied literature. METHODS: We advocate a simulation point of view for understanding competing risks. The hazards are envisaged as momentary event forces. They jointly determine the event time. Their relative magnitude determines the event type. 'Empirical simulations' using data from a recent study on cardiovascular events in diabetes patients illustrate subsequent interpretation. The method avoids concerns on identifiability and plausibility known from the latent failure time approach. RESULTS: The 'empirical simulations' served as a proof of concept. Additionally manipulating baseline hazards and treatment effects illustrated both scenarios that require greater care for interpretation and how the simulation point of view aids the interpretation. The simulation algorithm applied to real data also provides for a general tool for study planning. CONCLUSIONS: There are as many hazards as there are competing risks. All of them should be analysed. This includes estimation of baseline hazards. Study planning must equally account for these aspects. |
format | Online Article Text |
id | pubmed-3135581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31355812011-07-14 Understanding competing risks: a simulation point of view Allignol, Arthur Schumacher, Martin Wanner, Christoph Drechsler, Christiane Beyersmann, Jan BMC Med Res Methodol Research Article BACKGROUND: Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks. This is not always well accounted for in the applied literature. METHODS: We advocate a simulation point of view for understanding competing risks. The hazards are envisaged as momentary event forces. They jointly determine the event time. Their relative magnitude determines the event type. 'Empirical simulations' using data from a recent study on cardiovascular events in diabetes patients illustrate subsequent interpretation. The method avoids concerns on identifiability and plausibility known from the latent failure time approach. RESULTS: The 'empirical simulations' served as a proof of concept. Additionally manipulating baseline hazards and treatment effects illustrated both scenarios that require greater care for interpretation and how the simulation point of view aids the interpretation. The simulation algorithm applied to real data also provides for a general tool for study planning. CONCLUSIONS: There are as many hazards as there are competing risks. All of them should be analysed. This includes estimation of baseline hazards. Study planning must equally account for these aspects. BioMed Central 2011-06-03 /pmc/articles/PMC3135581/ /pubmed/21639902 http://dx.doi.org/10.1186/1471-2288-11-86 Text en Copyright ©2011 Allignol et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Allignol, Arthur Schumacher, Martin Wanner, Christoph Drechsler, Christiane Beyersmann, Jan Understanding competing risks: a simulation point of view |
title | Understanding competing risks: a simulation point of view |
title_full | Understanding competing risks: a simulation point of view |
title_fullStr | Understanding competing risks: a simulation point of view |
title_full_unstemmed | Understanding competing risks: a simulation point of view |
title_short | Understanding competing risks: a simulation point of view |
title_sort | understanding competing risks: a simulation point of view |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135581/ https://www.ncbi.nlm.nih.gov/pubmed/21639902 http://dx.doi.org/10.1186/1471-2288-11-86 |
work_keys_str_mv | AT allignolarthur understandingcompetingrisksasimulationpointofview AT schumachermartin understandingcompetingrisksasimulationpointofview AT wannerchristoph understandingcompetingrisksasimulationpointofview AT drechslerchristiane understandingcompetingrisksasimulationpointofview AT beyersmannjan understandingcompetingrisksasimulationpointofview |